2010 News | Events | Industry Updates
Selcia Limited is pleased to announce that its radiochemistry facility has been granted a Good Manufacturing Practice (GMP) certificate for the preparation of C-14 labeled Active Pharmaceutical Ingredients (APIs)
Building on an established partnership following significant progress made to date, Selcia’s chemists and biologists will continue to provide integrated drug discovery services to support Gilead’s liver disease research programmes.
Convergence Pharmaceuticals Limited, the new company focused on the development of novel and high value analgesic medicines, and Selcia Limited, today are pleased to announce that they have entered into a drug discovery collaboration
Selcia Limited today announced the high profile appointment of Simon Saxby to the Board as a non-executive director.
Selcia Discovery - New Fragment Screening Platform CEfrag™
Selcia Radiolabelling - GMP concepts synthesis - GLP analytics - Japanese market